SIMONE BLANK - 06 Sep 2022 Form 4 Insider Report for Evolus, Inc. (EOLS)

Role
Director
Signature
/s/ Jeffrey J. Plumer, as attorney-in-fact for Simone Blank
Issuer symbol
EOLS
Transactions as of
06 Sep 2022
Net transactions value
+$184,844
Form type
4
Filing time
08 Sep 2022, 09:29:12 UTC
Previous filing
26 Jan 2022
Next filing
31 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EOLS Common Stock Purchase $184,844 +20,000 +57% $9.24 54,881 06 Sep 2022 Direct F1, F2
holding EOLS Common Stock 367,577 06 Sep 2022 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were purchased in multiple trades at prices ranging from $9.08 to $9.52. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 Total includes 15,568 shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 24, 2022, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.
F3 Represents shares held by Dental Innovations Apus Investment BV ("DIAI) and may be deemed beneficially owned by the Reporting Person as the sole beneficial owner of DIAI.